American Academy of Neurology (AAN)
76^th Annual Meeting in Denver, Colo. (April 13-18, 2024)

• Lin C-Y, Yonce S, Pacini N, Yu M, Bishop J, Pavlik V, et al. Cerebello-parietal functional connectivity in amnestic mild cognitive impairment due to Alzheimer's disease. Presented at the American Academy of Neurology (AAN), 76^th Annual Meeting in Denver, Colo. (April 13-18, 2024).  

American Neuropsychiatric Association (ANPA)
34^th Annual Meeting in Houston, Texas (March 6-9, 2024)

• Lin CR, Yonce S, Pacini N, Yu MM, Bishop J, Pavlik VN, et al. Cerebello-parietal functional connectivity in amnestic mild cognitive impairment due to Alzheimer's disease. Presented at the American Neuropsychiatric Association (ANPA), 34^th Annual Meeting in Houston, Texas (March 6-9, 2024).  

American Academy of Neurology (AAN)
75^th Annual Meeting in Boston, Mass. (April 22-28, 2023)

• Rampalli I, Pavlik V, Yu M, Bishop J, Lin C. Cognitive function remains associated with global functional impairment in profound dementia due to Alzheimer's disease and dementia with Lewy bodies. Presented at the American Academy of Neurology (AAN), 75^th Annual Meeting in Boston, Mass. (April 22-28, 2023).  

2022 Alzheimer's Association International Conference (AAIC)
San Diego, Calif. (July 30 - Aug. 4, 2022)

• Pavlik VN. Reduced vascular disease mortality associated with improved 5-year survival in an AD cohort followed for 25 years. Presented at the 2022 Alzheimer's Association International Conference (AAIC), San Diego, Calif. (July 30 - Aug. 4, 2022). [Platform Presentation] 

2021 Alzheimer's Association International Conference (AAIC)
Virtual Meeting (July 26-30, 2021)

• Baker LD, Espeland MA, Whitmer RA, Kivipelto M, Antkowiak S, Chavin M, et al. U.S. POINTER: Lessons learned about delivery of a multi-domain lifestyle intervention during the COVID-19 pandemic. Presented at the 2021 Alzheimer's Association International Conference (AAIC), Virtual Meeting (July 26-30, 2021).  

2020 Alzheimer's Association International Conference (AAIC)
Virtual Meeting (July 27-31, 2020)

• Baker LD, Espeland MA, Kivipelto M, Whitmer RA, Snyder HM, Carrillo MC, et al. US-POINTER (USA). Presented at the 2020 Alzheimer's Association International Conference (AAIC), Virtual Meeting (July 27-31, 2020). [Platform Presentation] 
• Sood A, Pavlik VN, Darby E, Chan W, Doody R. Different profiles of cognitive deficits predict progression rate in probable AD. Presented at the 2020 Alzheimer's Association International Conference (AAIC), Virtual Meeting (July 27-31, 2020).  

2019 Alzheimer's Association International Conference (AAIC)
Los Angeles, Calif. (July 14-18, 2019)

• Szigeti K, Chen Z, Ouf A, Reisch J, Pavlik V, Wilding G. Cholinesterase inhibitors have a disease modifying effect in AD relative to CHRFAM7A genotype suggesting an a7NAChR dependent mechanism. Presented at the 2019 Alzheimer's Association International Conference (AAIC), Los Angeles, Calif. (July 14-18, 2019).  

14^th International Conference on Alzheimer's and Parkinson's Diseases (ADPD)
Lisbon, Portugal (March 26-31, 2019)

• Pavlik VN, Darby E, Kass JS. Temporal trends in mortality in an AD clinical cohort. Presented at the 14^th International Conference on Alzheimer's and Parkinson's Diseases (ADPD), Lisbon, Portugal (March 26-31, 2019).  

2018 Alzheimer's Association International Conference (AAIC)
Chicago, Ill. (July 22-26, 2018)

• Burham, SC, Colom PM, Datigues JF, Doody R, Hansson O, et al. Concord-AD: An international network of cohorts for better understanding of Alzheimer's disease. Alzheimers Dement. 2018;14(7 Suppl):P1465. 
• Pavlik VN, Darby E, Kass JS. Twenty year trends in proportional mortality in a probable AD cohort. Alzheimers Dement. 2018;14(7 Suppl):P958. 

American Academy of Neurology (AAN)
70^th Annual Meeting in Los Angeles, Calif. (April 21-27, 2018)

• Pavlik V, Chan W, Darby E. Validation of a pre-diagnostic progression rate used to predict post-diagnostic change on common Alzheimer's disease outcome measures. Neurology. 2018;90(15 Suppl):P5.188.  [View poster]

2017 Alzheimer's Association International Conference (AAIC)
London, United Kingdom (July 15-20, 2017)

• Pavlik VN, Bishop JS, Glosch C, Yu M, Darby E, Starks S, et al. Predictors of atypical antipsychotic treatment in an AD clinical population. Alzheimers Dement. 2017;13(7 Suppl):P742-3. 
• Pavlik VN, Chan W, Darby E, Kass JS. Cohort effects in progression rate in a clinical registry of Alzheimer's patients accrued from 1995-2010. Alzheimers Dement. 2017;13(7 Suppl):P381. 

North American Primary Care Research Group (NAPCRG)
2015 Practice-Based Research Network Conference in Bethesda, Md. (June 29-30, 2015)

• Brown A, Pavlik V, Zimmerman R, Danek L, Lacour-Chestnut F, Lateef M, et al. Selection of resources from a vaccination standing order program toolkit during a randomized trial to improve vaccination rates in a PBRN. Presented at the North American Primary Care Research Group (NAPCRG), 2015 Practice-Based Research Network Conference in Bethesda, Md. (June 29-30, 2015).  
• Pavlik V, Nash SG, Laufman L. Content of patient instructions section of an EHR generated after visit summary affects patient satisfaction. Presented at the North American Primary Care Research Group (NAPCRG), 2015 Practice-Based Research Network Conference in Bethesda, Md. (June 29-30, 2015).  

North American Primary Care Research Group (NAPCRG)
42^nd Annual Meeting in New York, N.Y. (Nov. 21-25, 2014)

• Almutairi A, Nash SG, Laufman LE, Pavlik V. Provider survey of attitudes toward and uses of an electronic after visit summary. Presented at the North American Primary Care Research Group (NAPCRG), 42^nd Annual Meeting in New York, N.Y. (Nov. 21-25, 2014).  
• Vaughan E, Aggarwal A, Pavlik V. Patterns of glycemic control with exclusive oral hypoglycemic agent use in a community health care setting. Presented at the North American Primary Care Research Group (NAPCRG), 42^nd Annual Meeting in New York, N.Y. (Nov. 21-25, 2014).  

American Neurological Association (ANA)
139^th Annual Meeting in Baltimore, Md. (Oct. 12-14, 2014)

• Majid T, Chan W, Darby E, Pavlik V, Doody R. Antioxidant biomarkers predict annualized change in MMSE score in MCI and AD patients in the TARCC cohort. Ann Neurol. 2014;76 Suppl 18:S94-5. 

North American Primary Care Research Group (NAPCRG)
2014 Practice-Based Research Network Conference in Bethesda, Md. (June 30 - July 1, 2014)

• Pavlik V, Campbell-Voytal K, Nash SG, Laufman L, Neale V. Development of a codebook to describe the content of the patient instructions section of an EHR-generated after visit summary. Presented at the North American Primary Care Research Group (NAPCRG), 2014 Practice-Based Research Network Conference in Bethesda, Md. (June 30 - July 1, 2014).  

National Academy of Neuropsychology (NAN)
32^nd Annual Meeting in Nashville, Tenn. (Nov. 7-10, 2012)

• Edwards M, Balldin V, Hall J, Strutt A, Pavlik V, Marquez de la Plata C, et al. Mexican American normative references on tasks of memory and language: The Texas Mexican American normative studies. Arch Clin Neuropsychol. 2012;27:659. 
• Hall J, Edwards M, Balldin V, Strutt A, Pavlik V, Marquez de la Plata C, et al. Normative data for Mexican American on tasks of executive and physiometric functions: The Texas Mexican American normative studies. Arch Clin Neuropsychol. 2012;27:582. 
• Hobson Balldin V, Menon C, Younes S, Hall J, Strutt A, Pavlik V, et al. Normative performance on the RBANS in a multi-ethnic bilingual cohort: The Texas Mexican American normative studies. Arch Clin Neuropsychol. 2012;27:652-3. 

Alzheimer's Association International Conference (AAIC)
Annual Meeting in Vancouver, British Columbia, Canada (July 14-19, 2012)

• Doody R, Chan W, Pavlik V, Rountree S, Massman P. Premorbid IQ and intrinsic progression rate explain substantial variance in observed progression of Alzheimer's disease (AD) on multiple measures. Alzheimers Dement. 2012;8(4 Suppl):P455. 
• McGee JS, Nguyen A, Darby E, Chan W, Pavlik V, Doody R. Factors influencing time to nursing home placement in persons with probable Alzheimer's disease. Alzheimers Dement. 2012;8(4 Suppl):P374.  [View poster]
• Rountree S, Chan W, Pavlik V, Doody R. Factors that influence long term care placement in an Alzheimer disease cohort. Alzheimers Dement. 2012;8(4 Suppl):P375.  [View poster]

American Society of Hypertension (ASH)
27^th Annual Scientific Meeting and Exposition in New York, N.Y. (May 19-22, 2012)

• Pavlik V, Chan W, Hyman D, Feldman P, Tobin J, Ogedegbe G, et al. Pooled analysis of three cluster randomized hypertension control trials in African-Americans. J Clin Hypertens (Greenwich). 2012;14(Suppl s1):10. 

2011 International Conference on Alzheimer's Disease (ICAD)
Paris, France (July 16-21, 2011)

• Doody R, Chan W, Ballantyne C, Pavlik V, Barber R, O'Bryant S, et al. Biomarkers associated with cardiovascular risk in the Texas Alzheimer's Disease Research and Care Consortium (TARCC) Cohort: LpPla2 and homocysteine. Alzheimers Dement. 2011;7(4 Suppl):S317-S8.  [View poster]
• Doody R, Chan W, Barber R, Ballantyne C, Pavlik V, O'Bryant S, et al. Inflammatory biomarkers in the Texas Alzheimer's Research and Care Consortium (TARCC) Cohort. Alzheimers Dement. 2011;7(4 Suppl):S318.  [View poster]
• Mielke M, Haughey N, Bandaru VVR, Weinberg D, Zaidi N, Pavlik V, et al. Plasma sphingomyelin is associated with cognitive progression in Alzheimer's disease. Alzheimers Dement. 2011;7(4 Suppl):S322-S3. 
• Pavlik V, Massman P, Rustveld L, Doody R. Racial/ethnic group differences in the association of APOE ε4 genotype and visuospatial test performance in a non-demented sample. Alzheimers Dement. 2011;7(4 Suppl):S361. 
• Rountree S, Chan W, Pavlik V, Darby E, Doody R. Factors that influence survival in Alzheimer's patients. Alzheimers Dement. 2011;7(4 Suppl):S513. 

American Academy of Neurology (AAN)
63^rd Annual Meeting in Honolulu, Hawaii (April 9-16, 2011)

• Pavlik V, Massman P, Ballantyne C, Barber R, Doody RS. Differences in the association of peripheral insulin and cognitive function in non-diabetic ad cases and normal controls. Neurology. 2011;76(Suppl 4):A122.  [View poster]

2010 International Conference on Alzheimer's Disease (ICAD)
Honolulu, Hawaii (July 10-15, 2010)

• Chan M, Pavlik VN, Chan W, Darby E, Khaleeq A, Doody RS. Presence of cardiovascular disease is associated with slower cognitive decline in Alzheimer's disease in the absence of cerebrovascular pathology. Alzheimers Dement. 2010;6(4 Suppl):S460.  [View poster]

American Academy of Neurology (AAN)
61^st Annual Meeting in Seattle, Wash. (April 25 - May 2, 2009)

• Doody R, Chan W, Pavlik V, Massman P, Darby E, Rountree S, et al. Age at onset and pre- morbid IQ influence early progression rates in AD. Neurology. 2009;72(11 Suppl 3):A478.  [View poster]

American Heart Association
Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Conference in Washington, DC (April 23-25, 2009)

• Pavlik V, Greisinger AJ, Hyman DJ. Systematic bias in blood pressure measurement between health care systems - Implications for quality of care research. Circ Cardiovasc Qual Outcomes. 2009;2(3):e49. 

2008 International Conference on Alzheimer's Disease (ICAD)
Chicago, Ill. (July 26-31, 2008)

• Rountree S, Pavlik V, Chan W, Doody RS. Persistent antidementia drug treatment and survival in an Alzheimer's disease (AD) cohort. Alzheimer's & Dementia. 2008;4(4 Suppl):T698-9.  [View poster]

American Academy of Neurology (AAN)
60^th Annual Meeting in Chicago, Ill. (April 12-19, 2008)

• Pavlik VN, Doody RS, Rountree SD, Darby EJ. Vitamin E use is associated with improved survival in an AD cohort. Neurology. 2008;70(11 Suppl 1):A146.  [View poster]

American Neurological Association (ANA)
132^nd Annual Meeting in Washington, DC (Oct. 7-10, 2007)

• Rountree SD, Chan W, Pavlik VN, Darby EJ, Siddiqui S, Gulley A, et al. Exposure to anti-dementia drugs slows clinical progression of Alzheimer's disease (AD). Ann Neurol. 2007;62 Suppl 11:S55.  [View poster]

Alzheimer's Association International Conference (AAIC)
Washington, DC (June 9-12, 2007)

• Rountree SD, Pavlik VN, Chan W, Darby EJ, Doody RS. Clinical factors associated with the preprogression rate (PPR) in Alzheimer's disease (AD). Alzheimers Dement. 2007;3(3 Suppl):S130.  [View poster]

American Heart Association
47^th Annual Conference on Cardiovascular Disease Epidemiology and Prevention in Orlando, Fla. (Feb. 28 - March 3, 2007)

• Pavlik, VN, Hyman DJ, Goodrick KG. Agreement between stage of change and measured behavioral endpoints: Implications for intervention design. Circulation. 2007;115(8):e279. 
• Rustveld LO, Pavlik VN. Association between serum c-peptide levels and the risk of cardiovascular disease in nondiabetic individuals: Data from the National Health and Nutrition Examination Survey. Circulation. 2007;115(8):e267. 

10^th International Conference on Alzheimer's Disease and Related Disorders
Madrid, Spain (July 15-20, 2006)

• Doody R, Pavlik V, Massman P, Rountree S, Waring S, Darby E, et al. Predicting progression and survival in Alzheimer's disease. Alzheimer's & Dementia. 2006;2(3 Suppl):S83. 
• Park KW, Pavlik VN, Rountree SD, Darby EJ, Doody RS. Is functional decline necessary for a diagnosis of Alzheimer's disease? Alzheimer's & Dementia. 2006;2(3 Suppl):S263.  [View poster]

American Academy of Neurology (AAN)
58^th Annual Meeting in San Diego, Calif. (April 1-8, 2006)

• Doody R, Pavlik V, Massman P, Rountree S, Darby E, Chan W. Predicting progression of Alzheimer's disease. Neurology. 2006;66(5 Suppl 2):A347.  [View poster]

American Heart Association/National Heart, Lung, and Blood Institute
46^th Annual Conference on Cardiovascular Disease Epidemiology and Prevention in Phoenix, Ariz. (March 2-5, 2006)

• Pavlik VN, Hyman DJ, Balasubramanyam A, Doody R. Association between cognitive function and metabolic control parameters in treated patients with type 2 diabetes. Circulation. 2006;113(8):e342. 

American Academy of Neurology (AAN)
57^th Annual Meeting in Miami Beach, Fla. (April 9-16, 2005)

• Pavlik V, Doody RS, Massman P, Chan W, Yeh S. Relationship of premorbid IQ and education to progression of Alzheimer's disease. Neurology. 2005;64(6 Suppl 1):A317.  [View poster]

Society for Epidemiologic Research (SER)
35^th Annual Meeting in Palm Desert, Calif. (June 19-21, 2002)

• Pavlik VN, Hyman DJ, Doody R. Cognitive function and cardiovascular risk factors in adults 30-59 years old (NHANES III). Am J Epidemiol. 2002;155(Suppl):S24. 

American Society of Hypertension (ASH)
17^th Annual Meeting in New York, N.Y. (May 14-18, 2002)

• Pavlik VN, Hyman DJ, Vallbona C, Grim C. Selective physician blood pressure remeasurement in the office setting may contribute to poor hypertension control. Am J Hypertens. 2002;15(4, Part 2):81A. 

North American Primary Care Research Group (NAPCRG)
29^th Annual Meeting in Halifax, Nova Scotia, Canada (Oct. 13-16, 2001)

• Pavlik VN, Maldonado M, Karlsson F, Schindler J, Spann SJ. Self-assessed knowledge of diabetes management in a low-income, minority patient population. Presented at the North American Primary Care Research Group (NAPCRG), 29^th Annual Meeting in Halifax, Nova Scotia, Canada (Oct. 13-16, 2001).  

North American Primary Care Research Group (NAPCRG)
28^th Annual Meeting in Amelia Island, Fla. (Nov. 4-7, 2000)

• Pavlik VN, Hyman DJ, Vallbona C. Improvement in systolic blood pressure control in a predominantly African-American health center. Presented at the North American Primary Care Research Group (NAPCRG), 28^th Annual Meeting in Amelia Island, Fla. (Nov. 4-7, 2000).  

American Society of Hypertension (ASH)
13^th Annual Meeting in New York, N.Y. (May 13-16, 1998)

• Hyman DJ, Ogbonnaya K, Pavlik VN, Taylor AA, Ho K. Ethnic differences in 24-hour blood pressure control in treated hypertensives. Presented at the American Society of Hypertension (ASH), 13^th Annual Meeting in New York, N.Y. (May 13-16, 1998).